GENEVA, Sept. 7 -- XELLSMART BIO-PHARMACEUTICAL (SUZHOU) CO., LTD. filed a patent application (CN2026/079902) for “USE OF COMBINATION THERAPY FOR ENHANCING NK CELLS IN TREATMENT OF MALIGNANT TUMORS”. With publication no. WO/2026/179877, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 35/17
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....